Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: NC NONMETROPOLITAN AREA — September 2026
Nonmetro NC biomanufacturing boom outpaces its talent pipeline.
J&J and Amgen are adding nearly 800 nonmetro jobs backed by $3B in capital, while metro Regulatory Affairs Specialist pay jumped to $111,259 as employers bid for scarce specialized talent.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- NC unemployment rate: 3.5% — vs 4.1% national, down 0.4pt year-over-year
- Regulatory Affairs pay: $111,259 — Metro median, up significantly vs stable $104K national
- New biomanufacturing investment: $3B — Amgen Holly Springs + J&J Wilson County, ~790 jobs
- NC labor force change: -70,000 — Year-over-year contraction statewide
Key takeaways
Biomanufacturing jobs are arriving faster than specialized talent can follow.
Amgen's Holly Springs and J&J's Wilson County projects add nearly 800 jobs and $3B in capital, but BioWork-style credential programs address operators, not the regulatory, quality, and CMC talent these facilities ultimately need. Expect sustained premiums for experienced hires willing to relocate into nonmetro sites.
Entry-level manufacturing pay now competes directly with four-year degree paths.
A $67,000 starting salary for a 19-year-old BioWork graduate at J&J reframes local wage expectations for technician and operator roles well above the metro's $47,794 lab technician median. Organizations benchmarking entry-level manufacturing comp against lab tech data may be understating what's required to compete for this pipeline.
Regulatory Affairs pay climbed while the national market held flat.
Metro Regulatory Affairs Specialist pay rose to a $111,259 median, a significant increase, while the national median sat stable near $104,000. Divergence this sharp in a nonmetro labor market suggests local employers are bidding specifically for scarce regulatory talent tied to the biomanufacturing buildout rather than following broader wage trends.
CDMO consolidation may expand the outsourcing bench, not just shrink it.
Kincellis Advanced Therapies' leadership hire from Resilience/Lyell/Pfizer signals cell therapy CDMO capacity consolidating around fewer, more capable providers. For build-vs-outsource decisions, this could mean fewer but deeper-capability partners available to absorb specialized workload that nonmetro sites can't staff internally.
Median advertised pay by role — NC NONMETROPOLITAN AREA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $122,366 | $160,000 | $160,000 | Significant increase | $131,354 |
| Clinical Research Associate | $60,971 | $86,420 | $106,131 | Significant increase | $90,956 |
| Lab Technician | $42,203 | $47,794 | $52,416 | Moderate decline | $47,402 |
| Regulatory Affairs Specialist | $72,894 | $111,259 | $133,194 | Significant increase | $104,000 |
| Clinical Data Manager | $114,378 | $121,658 | $134,198 | Significant decline | $123,031 |
| Biostatistician | $130,816 | $183,106 | $183,106 | Significant increase | $133,322 |
| Validation Engineer | $88,971 | $98,924 | $111,280 | Significant decline | $108,377 |
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Rural North Carolina's nonmetro counties remain tethered to statewide dynamics — 3.5% state unemployment and a labor force that contracted by roughly 70,000 people over the year — but biomanufacturing capital is landing disproportionately in micropolitan and nonmetro corridors, with Amgen's $1B Holly Springs expansion and J&J's $2B Wilson County biologics campus both situated outside core metro boundaries. Population outmigration and declining labor force participation in nonmetro counties collide directly with employers trying to staff large-scale manufacturing builds, tightening the pool for both operators and the specialized scientific oversight those facilities require.
What it means
Nonmetro life sciences employers face a structural mismatch: entry-level manufacturing roles can be filled through credential pipelines like Wilson Community College's BioWork program, but specialized scientific, quality, and regulatory talent must largely be recruited from outside the immediate labor shed, often from Raleigh-Durham's tighter 3.1% unemployment market. This pushes build-vs-outsource calculus toward hybrid models — local operator workforces paired with centralized or outsourced regulatory and quality functions — rather than assuming a single site can be fully self-sufficient on specialized headcount. Consider evaluating whether current site-level compensation structures account for the premium required to relocate or retain regulatory and quality leadership into nonmetro locations rather than benchmarking solely against metro rates.
Looking ahead
Expected: Watch whether Wilson Community College's pending $36.4M hub expansion accelerates graduate throughput fast enough to keep pace with J&J and Fresenius Kabi hiring timelines. A supply gap here would intensify competition for the limited pool of experienced line supervisors and technicians.
Emerging pressure point: NC Life Sciences Organization's Q3 forum publicly questioned whether the state's biomanufacturing workforce pipeline can meet demand — a signal worth tracking for whether employers begin raising nonmetro pay premiums or expanding remote/hybrid regulatory and quality roles to widen the recruiting radius.
Worth watching: Thirteen NC WARN notices in the past 90 days affected 1,336 workers, concentrated in manufacturing, transportation, and healthcare. Monitor whether any displaced manufacturing or quality talent flows into nonmetro life sciences openings, potentially easing near-term hiring pressure.
Potential inflection point: Raleigh-Cary's 3.1% unemployment versus the state's 3.6% keeps metro talent expensive and less mobile, reinforcing pressure on nonmetro sites to build rather than recruit senior regulatory and CMC talent. Watch whether relocation incentives or remote-eligible regulatory roles emerge as a competitive response.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.